Thanks to the support of the directors of the ARCND, the LNR will remain open and viable while we wrap up several important projects and collaborations.  We have a secure funding stream and the expectation is that the LNR will continue as before, but with clear end goals.  We are particularly thankful to the R&D management at Biogen and to our funders for facilitating this transition.